BTEC.L iShares Nasdaq US Biotechnology UCITS ETF | IE00BYXG2H39
Holdings & Portfolio Structure
Detailed breakdown of ETF components
ETF Concentration (Cumulative Weight)
Sector Distribution
Healthcare 98.32%
Unknown 1.54%
Industry Distribution
Biotechnology 66.71%
Drug Manufacturers - General 17.40%
Drug Manufacturers - Specialty & Generic 7.07%
Diagnostics & Research 5.78%
Unknown 1.54%
Health Information Services 1.06%
Medical Devices 0.18%
Medical Care Facilities 0.12%
Geographic Distribution
Loading TopoJSON...
All Holdings
Ticker | Name | Sector | Industry | Market Cap | Weight | P/E | Fwd P/E | Revenue Estimate | EPS Estimate |
|---|---|---|---|---|---|---|---|---|---|
| VRTX | Vertex Pharmaceuticals Incorpor | Healthcare | Biotechnology | 106,51 Mrd. € | 7.82% | 28.35 | 22.40 | CY +8.71% CQ +8.77% NY +9.98% NQ +4.15% | CY +3.06% CQ +5.04% NY +12.40% NQ +1.38% |
| AMGN | Amgen Inc. | Healthcare | Drug Manufacturers - General | 178,42 Mrd. € | 7.61% | 26.15 | 16.03 | CY +2.73% CQ +2.71% NY +2.47% NQ +2.80% | CY +2.29% CQ -6.70% NY +5.01% NQ +2.25% |
| GILD | Gilead Sciences, Inc. | Healthcare | Drug Manufacturers - General | 141,14 Mrd. € | 7.07% | 17.59 | 13.43 | CY +3.32% CQ +4.44% NY +6.12% NQ +5.38% | CY -109.38% CQ -461.75% NY +1359.59% NQ +130.36% |
| REGN | Regeneron Pharmaceuticals, Inc. | Healthcare | Biotechnology | 60,46 Mrd. € | 4.63% | 16.02 | 12.01 | CY +10.67% CQ +4.06% NY +10.93% NQ +9.72% | CY +3.47% CQ -20.43% NY +3.38% NQ +28.76% |
| ALNY | Alnylam Pharmaceuticals, Inc. | Healthcare | Biotechnology | 31,9 Mrd. € | 2.81% | 67.60 | 20.22 | CY +51.13% CQ +70.82% NY +29.04% NQ +11.86% | CY +85.50% CQ +573.48% NY +42.62% NQ +11.87% |
| RVMD | Revolution Medicines, Inc. | Healthcare | Biotechnology | 35,37 Mrd. € | 2.73% | - | -32.62 | CY - CQ - NY +753.46% NQ -52.17% | CY -35.59% CQ -57.02% NY +28.10% NQ +3.23% |
| MRNA | Moderna, Inc. | Healthcare | Biotechnology | 18,86 Mrd. € | 2.04% | - | -12.90 | CY +7.77% CQ -27.40% NY +21.79% NQ +778.73% | CY -19.26% CQ +3.33% NY +45.13% NQ +43.37% |
| BIIB | Biogen Inc. | Healthcare | Drug Manufacturers - General | 26,24 Mrd. € | 1.97% | 21.72 | 12.33 | CY +1.80% CQ -6.96% NY +2.47% NQ +4.07% | CY -21.30% CQ -61.33% NY +36.32% NQ +19.27% |
| ILMN | Illumina, Inc. | Healthcare | Diagnostics & Research | 25,82 Mrd. € | 1.97% | 35.35 | 32.71 | CY +5.24% CQ +6.78% NY +5.70% NQ +1.09% | CY +8.04% CQ +3.10% NY +13.46% NQ +10.73% |
| ROIV | Roivant Sciences Ltd. | Healthcare | Biotechnology | 22,14 Mrd. € | 1.78% | - | -22.45 | CY +496.63% CQ +7.80% NY +845.26% NQ +76.99% | CY -38.80% CQ -42.21% NY -4.25% NQ -11.52% |